Japanese neurosurgeons report two new strategies to improve outcomes of iPS cell-based therapies for Parkinson's disease in monkey brains. The findings are a key step for patient recruitment of the first iPS cell-based therapy to treat neurodegenerative diseases.
https://www.sciencedaily.com/releases/2017/08/170830132224.htm